Fentanyl Patch Overdose & Fentanyl Toxicity Death Lawsuits

Fentanyl Pain Patch Recall -  Recalled Fentanyl Transdermal Pain Patches Causing Fentanyl Overdose & Fentanyl Toxicity Deaths - Talk to a Lawyer - Free Case Consultation 1-800-883-9858

SEE: FDA Duragesic Fentanyl Patch Recall 

On February 12, 2008, PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.announced that all lots of 25 microgram/hour (mcg/hr) DURAGESIC® (fentanyl transdermal system) CII patches sold by PriCara in the United States and all 25 mcg/hr fentanyl patches sold by Sandoz Inc. in the United States are being voluntarily recalled. The recalled patches all have expiration dates on or before December 2009, and all are manufactured by ALZA Corporation, an affiliate of PriCara. The fentanyl recall is being conducted in cooperation with the U.S. Food and Drug Administration. All 25 mcg/hr fentanyl patches manufactured by ALZA and sold in Canada also are being recalled.

BREAKING NEWS:  All Actavis Fentanyl Patches Recalled

Actavis Fentanyl Transdermal System, 25 mcg/hr.     RECALLED
Actavis Fentanyl Transdermal System, 50 mcg/hr.     RECALLED
Actavis Fentanyl Transdermal System, 75 mcg/hr.     RECALLED
Actavis Fentanyl Transdermal System, 100 mcg/hr.   RECALLED

Fentanyl Patch Lawsuits - We Handle all cases on a Contigency Fee Basis !!

Contact us at 1-800-883-9858 or Click Here if you or a loved one suffered severe side effects or a death from a Fentanyl overdose caused by a defective Duragesic patch. The results of overdose from the Fentanyl patch can be severe. They include respiratory problems, decreased blood pressure, coma or even death. We understand the nature of this defect and the catastrophic consequences of a Fentanyl Overdose and we are here ready to assist you. .Call us if you have questions that need answers.

Recent FDA Alerts concerning Fentanyl Pain Patch Recall

• FDA Warning of Duragesic-July 2005
• Duragesic Patient Information- July 2005
• FDA Duragesic Alert-Dec. 21, 2007 (1)
• FDA Duragesic Alert- Dec. 21, 2007 (2)
• Duragesic Recall by FDA Feb. 12, 2008 - (NEW)
• Actavis Fentanyl Patch Recall- Feb. 17, 2008 (NEW)

FDA - Duragesic Fantanyl Patch Recall

NOTE: As of February 12, 2008 the FDA announced a PARTIAL Duragesic Patch Recall.

DURAGESIC 25 mcg/hr (fentanyl transdermal system) and Sandoz Inc. 25 mcg/hr fentanyl transdermal system patches being recalled may have a cut along one side of the drug reservoir within the patch. The result is possible release of fentanyl gel from the gel reservoir into the pouch in which the patch is packaged, exposing patients or caregivers directly to fentanyl gel. As per the approved product labeling for DURAGESIC, fentanyl is a potent Schedule II opioid medication. Fentanyl patches that are cut or damaged in any way should not be used. Exposure to fentanyl gel may lead to serious adverse events, including respiratory depression and possible overdose, which may be fatal.

Duragesic Patch Lawsuits & Class Actions

If you have suffered the lost a loved one due to an overdose of a DURAGESIC® due to the defective nature of the product packaging, then you may be eligible to file a products liability lawsuit / or a Fentanyl Patch Lawsuit for your injuries and losses.

Call and talk to a law firm that understands product liability lawsuits and class action lawsuits and the dangerous side affects from a overdose of fentanyl (a potent Schedule II opioid medication). Also, if you have sufffered the loss of a loved one, it is very important that you discuss your legal rights and options with a lawyer. The proper & safe storage of the evidence in any product liability lawsuit is critical. Call us with your questions.

Please call us at 1-800-883-9858 or fill out our Free Case Evaluation Form.